Clinical trials
Other Cancer clinical trials
Below are recruiting other cancer clinical trials, each written for real people, not researchers. We’re tracking 12,883 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06992336RecruitingPhase 2
Circulating tumor DNA guided extra treatment for early triple-negative breast cancer
This trial tests whether using a blood test to detect leftover cancer DNA after initial treatment can help doctors decide if extra therapy is needed for people with early triple-negative breast cancer. It aims to improve outcomes for those with remaining disease after neoadjuvant therapy.
Guangzhou, GuangodngAges 18–70 - NCT06992232RecruitingPhase 2
Radiation or surgery plus hormone therapy for prostate cancer that has spread
This trial tests whether giving intense hormone therapy along with either radiation or surgery can help men with prostate cancer that has spread to a limited number of spots (10 or fewer) but not to organs like the liver or lungs. The goal is to treat both the main tumor and the visible metastatic spots more aggressively.
Nanjing, JiangsuAges 18–80 - NCT07040280RecruitingPhase 2
Sulforaphane supplement to prevent new skin cancers in people with many atypical moles
This study tests a supplement made from broccoli sprouts (sulforaphane) to see if it can reduce the risk of developing new melanomas in people who have had melanoma before and have several unusual moles. Participants will take the supplement daily for a certain period and be monitored for skin changes.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT07040683Recruiting
Vacuum dressing for skin grafts on lower leg
This study compares standard wound care to a special vacuum dressing (negative pressure therapy) after skin graft surgery on the lower leg for skin cancer. The goal is to see if the vacuum dressing helps the graft heal better.
MalmöAges 18 years+ - NCT07039162RecruitingPhase 2
Tislelizumab with chemo and radiation before surgery for advanced esophageal cancer
This trial tests a combination of an immunotherapy drug (tislelizumab) with chemotherapy and radiation, followed by surgery, for people with advanced esophageal cancer that cannot be removed right away. It aims to see if this approach can help shrink the tumor enough to allow surgery.
Kaohsiung CityAges 20 years+ - NCT07035587Recruiting
A blood test to detect multiple cancers and monitor leftover tumors after treatment
This trial uses a blood test to find early signs of cancer or leftover tumor cells after treatment. It may help people with certain cancers or those with non-cancerous growths understand their condition better.
SeoulAges 19 years+ - NCT07043972RecruitingPhase 2
Gemcitabine and carboplatin after EV-pembrolizumab for bladder cancer
This trial tests a combination of two chemotherapy drugs, gemcitabine and carboplatin, for people whose bladder cancer has progressed after treatment with enfortumab vedotin plus pembrolizumab. The goal is to see if this chemo regimen can help control the cancer.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07040618Recruiting
Pain block comparison for lung cancer surgery
This trial compares two types of nerve blocks (rhomboid intercostal and erector spinae) to see which one provides better pain relief after lung cancer surgery. The goal is to find which block helps you recover more comfortably.
CairoAges 18–65 - NCT07039656RecruitingPhase 2
Toripalimab plus chemo after NSCLC surgery
This trial tests adding the immunotherapy drug toripalimab to chemotherapy after surgery for non-small cell lung cancer (NSCLC). It is for patients who either had no treatment before surgery or had chemo-immunotherapy before surgery and still have signs of cancer in their lymph nodes. The goal is to see if this combination helps prevent cancer from coming back.
Guangzhou, GuangdongAges 18–75 - NCT07041710Recruiting
Aromatherapy for taste and smell problems from chemo
This trial tests whether aromatherapy can help improve taste and smell problems caused by chemotherapy. It is for people who are still undergoing chemotherapy and have noticed these side effects.
VilleurbanneAges 18 years+ - NCT07038434Recruiting
Using artificial intelligence to measure pain in chronic pain patients
This study uses artificial intelligence to better understand and measure pain in people with chronic pain. The goal is to develop smarter ways to assess pain automatically, which could lead to better treatment.
Salerno, ItalyAges 18 years+ - NCT07042724Recruiting
Exercise and nutrition for early-stage lung cancer
This study explores whether a personalized exercise and nutrition program can improve outcomes for people with early-stage NSCLC. If you qualify, you will receive support from a health team and use a device to monitor your progress.
VeronaAges 18 years+ - NCT07034053RecruitingPhase 1/Phase 2
Clofarabine for advanced bladder cancer
This trial tests the drug clofarabine in people with advanced bladder cancer that has spread or cannot be removed by surgery. It is for those who have already tried standard treatments or chose not to have them.
ViennaAges 18 years+ - NCT07043491Recruiting
Comparing scopes and X-rays after esophagus surgery
This trial compares two ways doctors check the surgical connection (anastomosis) after removing a cancerous part of the esophagus. It looks at whether a flexible tube with a camera (endoscopy) or a special X-ray (esophagram) is better for routine follow-up.
Guangzhou, GuangdongAges 18 years+ - NCT07040189Recruiting
AI nutritional plan for taste changes from chemo
This study tests an AI-created diet plan to help with taste problems caused by chemotherapy. It may help manage taste issues by suggesting recipes tailored to you.
Munich, BavariaAges 18 years+ - NCT07038733Recruiting
Lymph node study for kidney cancer patients
This study looks at lymph nodes in people with known or suspected kidney cancer to learn more about the disease. It may help researchers understand how kidney cancer affects the lymph system.
New Haven, ConnecticutAges 18 years+ - NCT07035691Recruiting
New markers to better diagnose colorectal cancer referrals
This study looks for new markers in the blood or stool to help diagnose colorectal cancer earlier. It is for people who have been referred urgently because their doctor suspects lower bowel cancer.
London, EnglandAges 18 years+ - NCT07042919RecruitingPhase 1/Phase 2
Zanzalintinib for advanced liver cancer after prior treatment
This trial tests a new drug called zanzalintinib for people with advanced liver cancer (HCC) that can't be treated with surgery. You may join if your cancer has gotten worse after at least one prior treatment, or you couldn't tolerate that treatment.
Chicago, IllinoisAges 18 years+ - NCT06816836Recruiting
Measuring leg muscle mass to predict hospital stay after cancer surgery
This study uses ultrasound to measure leg muscle mass before surgery for gynecologic cancers, to see if it can predict how long you'll need to stay in the hospital after the operation.
Kolkata, West BengalAges 50–99 - NCT07024615RecruitingPhase 1
Study of ASP2138 before surgery for pancreatic cancer
This study tests an experimental drug, ASP2138, given before surgery for pancreatic cancer that is still removable. After surgery, you will receive standard chemotherapy. The goal is to see if adding ASP2138 before surgery helps improve outcomes.
Boston, MassachusettsAges 18 years+ - NCT07033689RecruitingEarly Phase 1
Testing Suizenji for newly diagnosed pancreatic cancer
This trial tests a new ultrasound treatment called Suizenji for people with pancreatic cancer that cannot be removed by surgery. The goal is to see if it can safely target the tumor.
San Francisco, CaliforniaAges 18 years+ - NCT06956144Recruiting
CAIX-targeted PET scan for kidney cancer
This trial uses a special PET scan that targets a protein (CAIX) often found in kidney cancer cells. It helps doctors see the cancer more clearly, which may guide better treatment decisions.
XiamenAges 18–74 - NCT06995157Recruiting
HPV infections and vaccine attitudes in Slovenian women
This observational study looks at HPV infections and women's views about the HPV vaccine in Slovenia. It aims to understand the characteristics of HPV infections and attitudes toward vaccination after the vaccine became available.
Ljubljana, Municipality of DomžaleAges Up to 35 years - NCT05727163RecruitingPhase 2
Liver-directed chemotherapy versus standard chemotherapy for RAS-mutated CRC
This Phase 2 study tests whether delivering chemotherapy directly into the liver (with an IV medicine added, depending on the group) works better than standard chemotherapy given through a vein. It is for people whose colorectal cancer has spread to the liver but can’t be removed by surgery yet.
Guangzhou, GuangdongAges 18–75
Hear when a new Other Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for other cancer?
- Yes. Clin2 currently lists 12,883 recruiting other cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a other cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a other cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.